Nabsys and Indiana University School of Medicine have launched a multi-year collaboration to develop electronic genome mapping applications for acute myeloid leukemia and myelodysplastic syndromes.
Read More
The test utilizes genomic sequencing and AI to identify biological signals associated with early-stage disease.
Read More
Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.
Read More
Optical genome mapping detected clinically significant genetic variants missed by standard tests in nearly 20% of acute leukemia cases, according to a 200-patient study.
Read More
Modern diagnostic tools are enabling higher-resolution HLA typing for stem cell transplants, supporting faster and more precise donor-recipient matching.
Read More